The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Cysteine Proteases: Modes of Activation and Future Prospects as Pharmacological Targets
Open accessAbstract
Proteolytic enzymes are crucial for a variety of biological processes in organisms ranging from lower (virus, bacteria, and parasite) to the higher organisms (mammals). Proteases cleave proteins into smaller fragments by catalyzing peptide bonds hydrolysis. Proteases are classified according to their catalytic site, and distributed into four major classes: cysteine proteases, serine proteases, aspartic proteases, and metalloproteases. This review will cover only cysteine proteases, papain family enzymes which are involved in multiple functions such as extracellular matrix turnover, antigen presentation, processing events, digestion, immune invasion, hemoglobin hydrolysis, parasite invasion, parasite egress, and processing surface proteins. Therefore, they are promising drug targets for various diseases. For preventing unwanted digestion, cysteine proteases are synthesized as zymogens, and contain a prodomain (regulatory) and a mature domain (catalytic). The prodomain acts as an endogenous inhibitor of the mature enzyme. For activation of the mature enzyme, removal of the prodomain is necessary and achieved by different modes. The pro-mature domain interaction can be categorized as protein-protein interactions (PPIs) and may be targeted in a range of diseases. Cysteine protease inhibitors are available that can block the active site but no such inhibitor available yet that can be targeted to block the pro-mature domain interactions and prevent it activation. This review specifically highlights the modes of activation (processing) of papain family enzymes, which involve auto-activation, trans-activation and also clarifies the future aspects of targeting PPIs to prevent the activation of cysteine proteases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tjäderhane, L., Buzalaf, M. A. R., Carrilho, M., & Chaussain, C. (2015) · Caries Research · doi:10.1159/000363582 · Cited by 2,306
Cysteine cathepsins: From structure, function and regulation to new frontiers
Turk, V., Stoka, V., Vasiljeva, O., Renko, M., Sun, T., Turk, B., & Turk, D. (2012) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2011.10.002 · Cited by 1,377
Cysteine proteases of parasitic organisms
Sajid, M., & McKerrow, J. H. (2002) · Molecular and Biochemical Parasitology · doi:10.1016/s0166-6851(01)00438-8 · Cited by 794
EMERGING ROLES FOR CYSTEINE PROTEASES IN HUMAN BIOLOGY
Chapman, H. A., Riese, R. J., & Shi, G.-P. (1997) · Annual Review of Physiology · doi:10.1146/annurev.physiol.59.1.63 · Cited by 786
HEMOGLOBIN METABOLISM IN THE MALARIA PARASITE PLASMODIUM FALCIPARUM
Francis, S. E., Sullivan, D. J., & Goldberg, A. D. E. (1997) · Annual Review of Microbiology · doi:10.1146/annurev.micro.51.1.97 · Cited by 782
Lecaille, F., Kaleta, J., & Brömme, D. (2002) · Chemical Reviews · doi:10.1021/cr0101656 · Cited by 519
Molecular mechanisms for the conversion of zymogens to active proteolytic enzymes
Khan, A. R., & James, M. N. G. (1998) · Protein Science · doi:10.1002/pro.5560070401 · Cited by 471
Emerging Roles of Cysteine Cathepsins in Disease and their Potential as Drug Targets
Vasiljeva, O., Reinheckel, T., Peters, C., Turk, D., Turk, V., & Turk, B. (2007) · Current Pharmaceutical Design · doi:10.2174/138161207780162962 · Cited by 450
Structure of human procathepsin L reveals the molecular basis of inhibition by the prosegment.
Coulombe, R., Grochulski, P., Sivaraman, J., Ménard, R., Mort, J. S., & Cygler, M. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00934.x · Cited by 388
THE LYSOSOMAL CYSTEINE PROTEASES
McGrath, M. E. (1999) · Annual Review of Biophysics and Biomolecular Structure · doi:10.1146/annurev.biophys.28.1.181 · Cited by 361
Cited by
The Ins and Outs of Cathepsins: Physiological Function and Role in Disease Management
Yadati, T., Houben, T., Bitorina, A., & Shiri-Sverdlov, R. (2020) · Cells · doi:10.3390/cells9071679 · Cited by 541
Total In Vitro Biosynthesis of the Thioamitide Thioholgamide and Investigation of the Pathway
Sikandar, A., Lopatniuk, M., Luzhetskyy, A., Müller, R., & Koehnke, J. (2022) · Journal of the American Chemical Society · doi:10.1021/jacs.2c00402 · Cited by 39
Yan, Y., Xiao, J., Huang, F., Xian, W., Yu, B., Cheng, R., Wu, H., Lu, X., Wang, X., Huang, W., et al. (2024) · Nature Microbiology · doi:10.1038/s41564-024-01684-z · Cited by 29
Structural insights into ubiquitin chain cleavage by Legionella ovarian tumor deubiquitinases
Kang, S., Kim, G., Choi, M., Jeong, M., van der Heden van Noort, G. J., Roh, S.-H., & Shin, D. (2023) · Life Science Alliance · doi:10.26508/lsa.202201876 · Cited by 9
Metadata
- Authors
- Verma, S., Dixit, R., & Pandey, K. C.
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2016-04-25
- Volume
- 7
- Pages
- 107-107
- ISSN
- 1663-9812 (ISSN-L)
- OpenAlex
- W2342445885
- Cited by
- 307
- References
- 67
- FWCI
- 7.64
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cysteine Proteases: Modes of Activation and Future Prospects as Pharmacological Targets. https://app.cochat.ai/papers/10.3389/fphar.2016.00107
- The paper
- Verma, S., Dixit, R., & Pandey, K. C. (2016). Cysteine Proteases: Modes of Activation and Future Prospects as Pharmacological Targets. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2016.00107
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.